key: cord-0756894-w9h0d1fi
authors: Kwarteng, Alexander; Asiedu, Ebenezer; Sylverken, Augustina Angelina; Larbi, Amma; Sakyi, Samuel Amoah; Asiedu, Samuel Opoku
title: Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach
date: 2021-03-24
journal: Infect Genet Evol
DOI: 10.1016/j.meegid.2021.104815
sha: a60242217d5d30c6c3363dd48d38b812fee462bb
doc_id: 756894
cord_uid: w9h0d1fi

The D614G variant of SARS-CoV-2 S-protein emerged in early 2020 and quickly became the dominant circulating strain in Europe and its environs. The variant was characterized by the higher viral load, which is not associated with disease severity, higher incorporation into the virion, and high cell entry via ACE-2 and TMPRSS2. Previous strains of the coronavirus and the current SARS-CoV-2 have demonstrated the selection of mutations as a mechanism of escaping immune responses. In this study, we used molecular dynamics simulation and MM-PBSA binding energy analysis to provide insights into the behaviour of the D614G S-protein at the molecular level and describe the neutralization mechanism of this variant. Our results show that the D614G S-protein adopts distinct conformational dynamics which is skewed towards the open-state conformation more than the closed-state conformation of the wild-type S-protein. Residue-specific variation of amino acid flexibility and domain-specific RMSD suggest that the mutation causes an allosteric conformational change in the RBD. Evaluation of the interaction energies between the S-protein and neutralizing antibodies show that the mutation may enhance, reduce or not affect the neutralizing interactions depending on the neutralizing antibody, especially if it targets the RBD. The results of this study have shed insights into the behaviour of the D614G S-protein at the molecular level and provided a glimpse of the neutralization mechanism of this variant.

Severe acute respiratory syndrome associated coronavirus 2 (SARS-CoV-2) is the causative agent of the 2019 coronavirus disease , which was declared a pandemic by the World Health Organization (WHO) on March 11, 2020. The period between the latter part of February and March 2020 saw the emergence of the SARS-The S-protein is comprised of the S1 and S2 subunits. The S1-subunit has three domains: N-terminal domain (NTD), C-terminal domain (CTD) and receptor-binding domain (RBD). The mechanism of neutralization of the SARS-CoV-2 by antibodies involves binding the neutralizing antibody to the RBD or NTD, with the aim of interfering interactions with human angiotensin-converting enzyme 2 (ACE-2) (Barnes et al., 2020; Piccoli et al., 2020) . Previous strains of the coronavirus outbreaks and the current SARS-CoV-2 can manipulate their genomes to select mutations resistant to monoclonal antibodies or convalescent plasma (Li et al., 2020; Sui et al., 2008; Tang et al., 2018; ter Meulen et al., 2006) .

The D614G variant has been characterized by higher viral load, which is not associated with disease severity (Korber et al., 2020; Volz et al., 2021) , higher incorporation into virion , and high cell entry via ACE-2 and TMPRSS2 (Ogawa et al., 2020; Ozono et al., 2021) . The molecular features of the D614G S-protein conformational dynamics and its potential effect on the interactions with neutralizing antibodies have not been extensively looked at. In this study, we used molecular dynamics simulation and MM-PBSA binding energy analysis to provide insights into the behaviour of the D614G S-protein and describe the neutralization interactions between the variant and neutralizing antibodies. Our results show that the D614G S-protein adopts distinct conformational dynamics, which is skewed towards the open-state conformation more than the closed-state conformation of the wild-type S-protein. Residue-specific variation of amino acid flexibility and domain-specific RMSD suggest that the mutation causes an allosteric conformational change in the RBD. Evaluation of the interaction energies between the S-protein and neutralizing antibodies show that the mutation may increase, decrease or not affect the neutralizing interactions depending on the neutralizing antibody.

Journal Pre-proof

The UniProt database (https://www.uniprot.org/uniprot/) was used to access the sequence of SARS-CoV-2 S protein Wuhan reference. All protein models were generated and validated using the SWISS-MODEL server (https://swissmodel.expasy.org/). The S-protein models used in this study were the D614G variant of the SARS-CoV-2 S-protein and the wild-type S-protein (closedstate and open-state). The mutation of aspartate-614 to glycine was accomplished by the PyMol mutagenesis tool (Yuan et al., 2017) . The structural co-ordinates of the templates were obtained from the Protein Data Bank (https://www.rcsb.org/).

The ConSurf server was used to calculate the evolutionary conservation degree of each SARS-CoV-2 S-protein residue. The server (http://consurf.tau.ac.il) provides an evolutionary profile of the amino acids, which define their level of importance to the protein's biological activity and structure. The following parameters were selected for MAFFT-L-INS-i; and evolutionary substitution model: best model.

The studied molecular systems were comprised of the selected neutralizing antibodies (antigen-binding fragment, Fab) bound to the RBD or NTD of the SARS-CoV-2 Sprotein (wild-type or D614G variant). The complexes were generated through the structural superposition of the templates and the generated models using the PyMol v2.4.

J o u r n a l P r e -p r o o f Journal Pre-proof

The wild-type and D614G S-protein systems were simulated using GROMACS v2021 (Abraham et al., 2015) and CHARMM36 force field (Vanommeslaeghe et al., 2010) .

The proteins were centered in a cubic box, placed 1 nm from the box edges and solvated with a three-point (tip3p) water model. Appropriate ions were added to the system to neutralize the molecular system electrostatically. Energy minimization was performed on the system using the steepest descent algorithm for 20,000 steps with a maximum force threshold of 100 kJ/mol/nm. Van der Waals interactions were treated with a single cut-off of 1.4 nm and long-range electrostatics were treated at a cut-off of 1.4 nm with the Particle-Mesh Ewald (PME) method with 0.168 FFT grid spacing and 4 th order B-spline interpolation. Neighbour search was performed every 20 steps using the grid method with Verlet cut-off scheme. Protein and non-protein components of the system were independently coupled to v-rescale thermostat and an isotropic Berendsen algorithm for pressure coupling. The pressure was maintained by weak coupling to a reference pressure of 1 bar, with an isothermal compressibility of 4.6x10 5 bar-1. The bond lengths within the protein were constrained using the LINCS algorithm. NVT and NPT equilibrations were run for a total of 400 ps. Three independent simulations of 100 ns each were performed for all molecular systems.

For MM-PBSA calculations, a total of 15 ns simulations was performed for each complex in triplicate using GROMACS v5.1.5.

governing the S-protein-antibody interactions were calculated using the g_mmpbsa v5.1.2 (Kumari et al., 2014) , which is based on the Molecular Mechanics with

Poisson-Boltzmann Surface Area (MM-PBSA) approach. The binding energy (E binding )

of the system is estimated as;

where, E mm represents the molecular mechanics energy terms, G solv represents the solvation energy terms. It is worth noting that the entropic term (TS) is exempted from the calculation particularly due to the high computational demand. There are reports demonstrating that the net contribution of the entropic term is often minimal (Kumari et al., 2014) . This is why the binding energy is designated as E binding instead of ΔG. wild-type and D614G S-protein RMSD. P < 0.05 was considered to be statistically significant.

Journal Pre-proof 3. Results

The crystallographic structures of SARS-CoV-2 S-protein at the PDB are averaged models of the resolved protein in solutions, and these structures may lack some fragments and residues (Deller et al., 2015) . Accordingly, we used SWISS-MODEL to Ngoi et al., 2020) . These low conserved residues may be frequently mutated to enhance the escape mechanism adopted by the virus. The residue conservation analysis revealed that aspartate-614 (D614) is a moderately conserved residue with ConSurf score of 6 ( Fig. 1d) , suggesting an important role for the residue in the biological activity and dynamics of the S-protein.

The structural impact of the mutation was studied through all-atom molecular simulation of the S-protein. The root-mean-square-deviation (RMSD) and root-meansquare-fluctuation (RMSF) were used to assess the dynamics of the S-protein. The RMSD represents the conformational stability of the protein system during the simulation because it reflects the average displacement of backbone atoms in the protein structure with reference to the starting structure (equilibrated structure, t = 0 ns). We have also used the RMSD parameter to decide the similarities or differences between the wild-type, D614G and open-state S-proteins.

The RMSD evolution of the molecular systems during the simulations is shown in J o u r n a l P r e -p r o o f Journal Pre-proof

Analysis of the molecular dynamics simulation trajectories and structures have shown that the D614G S-protein has distinct structural conformation and residue-specific The decomposition of the binding energy into separate energy terms shows that the electrostatic energy term is the major source of the varying binding energy observed for the interactions with the CB6 ( (Kumari et al., 2014) . The polar solvation energy term is the electrostatic contribution to the free energy of solvation (Kumari et al., 2014) , thus is related to the electrostatic energy term. Estimating the MM-PBSA binding energy has shown that the D614G S-

Journal Pre-proof protein has better interactions with the CB6 than the wild-type S-protein, but comparable interactions with 4A8 and P2B-2F6. The difference in interaction with CB6 was driven by a large difference in the electrostatic energy contribution, which involves the interactions between charged amino acid residues and the interacting interface.

We have further decomposed the binding energy based on residual contributions in order to identify the differences in residue contributions to the binding energy. The favorable energy contributions from the residues towards the binding of the neutralizing antibodies are shown in Figure 7 . Concerning the interactions with CB6, energy contributions for some residues varied for the wild-type and D614G Sproteins. These residues (shown in Fig. 7a ) contributed higher energies to the D614G-CB6 interaction than the wild-CB6 interaction.

Unlike CB6, the contributions from key residues to the interactions with P2B-2F6 and 4A8 were comparable for the wild-type and D614G S-proteins ( Fig. 7b and 7c) , which resulted in the highly similar total binding energies for these interactions.

Mapping of the residue energy contributions to the structure of the RBD-CB6

interaction interface revealed further support to the observed variation in residue contributions. The contributions from wild-type S-protein residues ranged from -54.6

to 58.2 kJ/mol and -39.5 to 36.0 kJ/mol from the D614G S-protein residues. Seven key residues with varying energy contributions to the CB6 interactions were noticed (Fig. 8) .

In this study, we used molecular dynamics simulation to explore the structural conformation of the wild-type and the D614G S-proteins of SARS-CoV-2 and provide a plausible description of the impact the mutation has on the molecular J o u r n a l P r e -p r o o f Journal Pre-proof features of interaction with neutralization antibodies. Previous strains of the coronavirus and the current SARS-CoV-2 have demonstrated the selection of mutations as a mechanism of escaping immune responses against them (Li et al., 2020; Sui et al., 2008; Tang et al., 2018; ter Meulen et al., 2006) . Moreover, variants that confer resistance to neutralizing antibodies or convalescent plasma may have been selected but are present at low frequencies in SARS-CoV-2 infected populations . The D614G variant emerged around late January to mid-February 2020 and within 1 month, emerged as the dominant circulating strain in Europe and its environs (Isabel et al., 2020; Korber et al., 2020) . The variant was characterized by the higher viral load, which is not associated with disease severity (Korber et al., 2020; Volz et al., 2021) , higher incorporation into virion , and higher cell entry via ACE-2 and TMPRSS2 (Ogawa et al., 2020; Ozono et al., 2021) . The results of this study have shed insights into the behaviour of the D614G S-protein at the molecular level and provided a glimpse of the neutralization mechanism of this variant.

The results of this study data show that the D614G S-protein adopts a conformation that is skewed towards the open-state conformation more than the wild-type conformation. Similar observations have been reported previously (Mansbach et al., 2020; Yurkovetskiy, Wang, et al., 2020) . Our data also shows that there is an and 4A8 were selected to represent groups 1, 2 and 3, respectively. Unlike P2B-2F6 and 4A8, we noticed a huge difference in the interactions with CB6. The D614G Sprotein interacted with the CB6 antibody better than the wild-type. This change in affinity was as a result of large difference in the electrostatic energy contributions.

The electrostatic energy term involves interactions between charged amino acids at the interaction interface of the RBD-CB6 complex. There is a possibility that the mutation induces changes in RBD conformational dynamics, thereby exposing otherwise buried residues as previously suggested (Weissman et al., 2021) . The RBD also harbors several charged amino acids that are available for interaction with the ACE-2 receptor only in the open-state (Yi et al., 2020) .

The results suggest that the mutation may enhance, reduce or not affect the neutralizing interactions depending on the neutralizing antibody. In this study, the mutation reduced the interaction with CB6 but no effect was noticed on the interactions with 4A8 and P2B-2F6. SARS-CoV-2 neutralizing assay data from Chile demonstrated that some samples from individuals exposed to the virus showed enhanced or decreased neutralizing activity against the D614G variant compared to the wild-type (Beltrán-Pavez et al., 2021) . In another study, the D614G variant was more susceptible to neutralization by RBD monoclonal antibodies and convalescent sera from individuals infected with the virus (Weissman et al., 2021) . Several studies have reported that there is a similar neutralizing potency of the wild-type and D614G

J o u r n a l P r e -p r o o f Journal Pre-proof variant when treated with convalescent sera of individuals exposed to the virus (Lee et al., 2021; Yurkovetskiy et al., 2020; .

In summary, our results show that the D614G S-protein adopts a distinct conformational dynamics, which is skewed towards the open-state conformation more than the wild-type conformation. Residue-specific variation of amino acid flexibility and domain-specific RMSD suggest that the mutation causes an allosteric conformational change in the RBD. Evaluation of the interaction energies between the S-protein and neutralizing antibodies show that the mutation may increase, decrease or not affect the neutralizing interactions depending on the neutralizing antibody. 

ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

Models of protein-ligand crystal structures: trust, but verify

Structural flexibility and protein adaptation to temperature: Molecular dynamics analysis of malate dehydrogenases of marine molluscs

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USA

Article Tracking Changes in SARS-CoV-2 Spike : Evidence that D614G Increases Infectivity of the COVID-ll Tracking Changes in SARS-CoV-2 Spike : Evidence that D614G Increases Infectivity of the COVID-19 Virus

g_mmpbsa--a GROMACS tool for highthroughput MM-PBSA calculations

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant

The SARS-CoV-2 Spike Variant D614G Favors an Open Conformational State

Genomic analysis of SARS-CoV-2 reveals local viral evolution in Ghana

The D614G mutation in the SARS-CoV2 Spike protein increases infectivity in an ACE2 receptor dependent manner

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution

A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

Characterization of the receptorbinding domain ( RBD ) of 2019 novel coronavirus : implication for development of RBD protein as a viral attachment inhibitor and vaccine

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies

Using PyMOL as a platform for computational drug design

SARS-CoV-2 Spike protein variant D614G increases infectivity and retains sensitivity to antibodies that target the receptor binding domain

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

SARS-CoV-2 spike-protein D614G mutation increases virion spike